Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ensuring Effective Prevention of Iodine Deficiency Disorders.
Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gaberšček S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusić Z, Laurberg P, Lazarus JH, Markou KB, Moreno-Reyes R, Nagy EV, Peeters RP, Pīrāgs V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB. Völzke H, et al. Among authors: siebert u. Thyroid. 2016 Feb;26(2):189-96. doi: 10.1089/thy.2015.0543. Epub 2016 Jan 25. Thyroid. 2016. PMID: 26700864
Medical decision analysis for first-line therapy of chronic myeloid leukemia.
Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Radich J, Gastl G, Siebert U. Rochau U, et al. Among authors: siebert u. Leuk Lymphoma. 2014 Aug;55(8):1758-67. doi: 10.3109/10428194.2013.858149. Epub 2014 Feb 6. Leuk Lymphoma. 2014. PMID: 24160847
Systematic assessment of decision-analytic models for chronic myeloid leukemia.
Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Rochau U, et al. Among authors: siebert u. Appl Health Econ Health Policy. 2014 Apr;12(2):103-15. doi: 10.1007/s40258-013-0071-8. Appl Health Econ Health Policy. 2014. PMID: 24385259 Review.
Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U, Jahn B, Rochau U, Schnell-Inderst P, Kisser A, Hunger T, Sroczynski G, Mühlberger N, Willenbacher W, Schnaiter S, Endel G, Huber L, Gastl G; Oncotyrol HTA & Outcomes Research Working Group. Siebert U, et al. Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):330-40. doi: 10.1016/j.zefq.2015.06.012. Epub 2015 Jul 28. Z Evid Fortbild Qual Gesundhwes. 2015. PMID: 26354133
Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics.
Willenbacher E, Weger R, Rochau U, Siebert U, Willenbacher W; Austrian Myeloma Registry (AMR). Willenbacher E, et al. Among authors: siebert u. PLoS One. 2016 Mar 3;11(3):e0147381. doi: 10.1371/journal.pone.0147381. eCollection 2016. PLoS One. 2016. PMID: 26937956 Free PMC article.
Systematic Overview On Value-Of Information Analyses In Cancer Research.
Rochau U, Schnell-Inderst P, Burger EA, Baldauf M, Kühne F, Jahn B, Siebert U. Rochau U, et al. Among authors: siebert u. Value Health. 2014 Nov;17(7):A559. doi: 10.1016/j.jval.2014.08.1846. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201842 Free article. No abstract available.
668 results